5511. Vedolizumab treatment persistence and safety in a 2‐year data analysis of an extended access programme. Issue 2 (18th November 2020) Authors: Danese, Silvio; Subramaniam, Kavitha; Van Zyl, Jan; Adsul, Shashi; Lindner, Dirk; Roth, Jeannine; Vermeire, Séverine Journal: Alimentary pharmacology & therapeutics Issue: Volume 53:Issue 2(2021) Page Start: 265 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5512. Vedolizumab use is not associated with increased malignancy incidence: GEMINI LTS study results and post‐marketing data. Issue 1 (20th November 2019) Authors: Card, Timothy; Ungaro, Ryan; Bhayat, Fatima; Blake, Aimee; Hantsbarger, Gary; Travis, Simon Journal: Alimentary pharmacology & therapeutics Issue: Volume 51:Issue 1(2020) Page Start: 149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5513. Velusetrag accelerates gastric emptying in subjects with gastroparesis: a multicentre, double‐blind, randomised, placebo‐controlled, phase 2 study. Issue 10 (3rd April 2021) Authors: Kuo, Braden; Barnes, Chris N.; Nguyen, Deanna D.; Shaywitz, David; Grimaldi, Maria; Renzulli, Cecilia; Canafax, Daniel; Parkman, Henry P. Journal: Alimentary pharmacology & therapeutics Issue: Volume 53:Issue 10(2021) Page Start: 1090 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5514. Venous thromboembolic events in the tofacitinib ulcerative colitis clinical development programme. Issue 10 (9th October 2019) Authors: Sandborn, William J.; Panés, Julian; Sands, Bruce E.; Reinisch, Walter; Su, Chinyu; Lawendy, Nervin; Koram, Nana; Fan, Haiyun; Jones, Thomas V.; Modesto, Irene; Quirk, Daniel; Danese, Silvio Journal: Alimentary pharmacology & therapeutics Issue: Volume 50:Issue 10(2019) Page Start: 1068 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5515. Very low probability of significant liver inflammation in chronic hepatitis B patients with low ALT levels in the absence of liver fibrosis. Issue 8 (4th September 2020) Authors: Sonneveld, Milan J.; Brouwer, Willem P.; Hansen, Bettina E.; Chan, Henry L.‐Y.; Piratvisuth, Teerha; Jia, Ji‐Dong; Zeuzem, Stefan; Chien, Rong‐Nan; Choi, Hannah; de Knegt, Robert J.; Wat, Cynthia; Pavlovic, Vedran; Gaggar, Anuj; Xie, Qing; Buti, Maria; de Man, Robert A.; Janssen, Harry L.A. Journal: Alimentary pharmacology & therapeutics Issue: Volume 52:Issue 8(2020) Page Start: 1399 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5516. Vigorous physical activity provides protection against all‐cause deaths among adults patients with nonalcoholic fatty liver disease (NAFLD). Issue 6 (15th November 2022) Authors: Henry, Austin; Paik, James M.; Austin, Patrick; Eberly, Katherine Elizabeth; Golabi, Pegah; Younossi, Issah; Henry, Linda; Gerber, Lynn; Younossi, Zobair M. Journal: Alimentary pharmacology & therapeutics Issue: Volume 57:Issue 6(2023) Page Start: 709 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5517. Viral eradication reduces both liver stiffness and steatosis in patients with chronic hepatitis C virus infection who received direct‐acting anti‐viral therapy. Issue 7 (9th February 2018) Authors: Tada, T.; Kumada, T.; Toyoda, H.; Sone, Y.; Takeshima, K.; Ogawa, S.; Goto, T.; Wakahata, A.; Nakashima, M.; Nakamuta, M.; Tanaka, J. Journal: Alimentary pharmacology & therapeutics Issue: Volume 47:Issue 7(2018) Page Start: 1012 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5518. Viral kinetics analysis and virological characterization of treatment failures in patients with chronic hepatitis C treated with sofosbuvir and an NS5A inhibitor. Issue 5 (22nd December 2017) Authors: Fourati, S.; Guedj, J.; Chevaliez, S.; Nguyen, T. H. T.; Roudot‐Thoraval, F.; Ruiz, I.; Soulier, A.; Scoazec, G.; Varaut, A.; Poiteau, L.; Francois, M.; Mallat, A.; Hézode, C.; Pawlotsky, J.‐M. Journal: Alimentary pharmacology & therapeutics Issue: Volume 47:Issue 5(2018) Page Start: 665 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5519. Virological outcomes and treatment algorithms utilisation in observational study of patients with chronic hepatitis C treated with boceprevir or telaprevir. Issue 7 (28th January 2015) Authors: Sterling, R. K.; Kuo, A.; Rustgi, V. K.; Sulkowski, M. S.; Stewart, T. G.; Fenkel, J. M.; El‐Genaidi, H.; Mah'moud, M. A.; Abraham, G. M.; Stewart, P. W.; Akushevich, L.; Nelson, D. R.; Fried, M. W.; Di Bisceglie, A. M. Journal: Alimentary pharmacology & therapeutics Issue: Volume 41:Issue 7(2015) Page Start: 671 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5520. Visceral adiposity predicts post‐operative Crohn's disease recurrence. Issue 9 (28th February 2017) Authors: Holt, D. Q.; Moore, G. T.; Strauss, B. J. G.; Hamilton, A. L.; De Cruz, P.; Kamm, M. A. Journal: Alimentary pharmacology & therapeutics Issue: Volume 45:Issue 9(2017) Page Start: 1255 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗